Exact Mass: 403.206
Exact Mass Matches: 403.206
Found 342 metabolites which its exact mass value is equals to given mass value 403.206
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3,4-Dihydroxy-tamoxifen
3,4-Dihydroxy-tamoxifen is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)
BENZOYLARGININE-2-NAPHTHYLAMIDE
Benzoyl-DL-arginine-naphthylamide
rel-(1S,2R,3aS,8S,10aR,10bR)-1-ethyl-3a,5,6,8,9,10,10a,10b-octahydro-4-methyl-8-[(2S,4S)-tetrahydro-4-methyl-5-oxofuran-2-yl]-5H-spiro[furan-2,2-furo[3,2-c]pyrrolo[1,2-a]azepine]-4,5(1H)-dione|stemonine
Ala Ala Asp Lys
Ala Ala Lys Asp
Ala Asp Ala Lys
Ala Asp Lys Ala
Ala Glu Gly Lys
Ala Glu Lys Gly
Ala Gly Glu Lys
Ala Gly Lys Glu
Ala Ile Asn Ser
Ala Ile Ser Asn
Ala Lys Ala Asp
Ala Lys Asp Ala
Ala Lys Glu Gly
Ala Lys Gly Glu
Ala Leu Asn Ser
Ala Leu Ser Asn
Ala Asn Ile Ser
Ala Asn Leu Ser
Ala Asn Ser Ile
Ala Asn Ser Leu
Ala Asn Thr Val
Ala Asn Val Thr
Ala Gln Ser Val
Ala Gln Val Ser
Ala Ser Ile Asn
Ala Ser Leu Asn
Ala Ser Asn Ile
Ala Ser Asn Leu
Ala Ser Gln Val
Ala Ser Val Gln
Ala Thr Asn Val
Ala Thr Val Asn
Ala Val Asn Thr
Ala Val Gln Ser
Ala Val Ser Gln
Ala Val Thr Asn
Asp Ala Ala Lys
Asp Ala Lys Ala
Asp Lys Ala Ala
Glu Ala Gly Lys
Glu Ala Lys Gly
Glu Gly Ala Lys
Glu Gly Lys Ala
Glu Lys Ala Gly
Glu Lys Gly Ala
Gly Ala Glu Lys
Gly Ala Lys Glu
Gly Glu Ala Lys
Gly Glu Lys Ala
Gly Ile Asn Thr
Gly Ile Gln Ser
Gly Ile Ser Gln
Gly Ile Thr Asn
Gly Lys Ala Glu
Gly Lys Glu Ala
Gly Leu Asn Thr
Gly Leu Gln Ser
Gly Leu Ser Gln
Gly Leu Thr Asn
Gly Asn Ile Thr
Gly Asn Leu Thr
Gly Asn Thr Ile
Gly Asn Thr Leu
Gly Gln Ile Ser
Gly Gln Leu Ser
Gly Gln Ser Ile
Gly Gln Ser Leu
Gly Gln Thr Val
Gly Gln Val Thr
Gly Ser Ile Gln
Gly Ser Leu Gln
Gly Ser Gln Ile
Gly Ser Gln Leu
Gly Thr Ile Asn
Gly Thr Leu Asn
Gly Thr Asn Ile
Gly Thr Asn Leu
Gly Thr Gln Val
Gly Thr Val Gln
Gly Val Gln Thr
Gly Val Thr Gln
Ile Ala Asn Ser
Ile Ala Ser Asn
Ile Gly Asn Thr
Ile Gly Gln Ser
Ile Gly Ser Gln
Ile Gly Thr Asn
Ile Asn Ala Ser
Ile Asn Gly Thr
Ile Asn Ser Ala
Ile Asn Thr Gly
Ile Gln Gly Ser
Ile Gln Ser Gly
Ile Ser Ala Asn
Ile Ser Gly Gln
Ile Ser Asn Ala
Ile Ser Gln Gly
Ile Thr Gly Asn
Ile Thr Asn Gly
Lys Ala Ala Asp
Lys Ala Asp Ala
Lys Ala Glu Gly
Lys Ala Gly Glu
Lys Asp Ala Ala
Lys Glu Ala Gly
Lys Glu Gly Ala
Lys Gly Ala Glu
Lys Gly Glu Ala
Leu Ala Asn Ser
Leu Ala Ser Asn
Leu Gly Asn Thr
Leu Gly Gln Ser
Leu Gly Ser Gln
Leu Gly Thr Asn
Leu Asn Ala Ser
Leu Asn Gly Thr
Leu Asn Ser Ala
Leu Asn Thr Gly
Leu Gln Gly Ser
Leu Gln Ser Gly
Leu Ser Ala Asn
Leu Ser Gly Gln
Leu Ser Asn Ala
Leu Ser Gln Gly
Leu Thr Gly Asn
Leu Thr Asn Gly
Asn Ala Ile Ser
Asn Ala Leu Ser
Asn Ala Ser Ile
Asn Ala Ser Leu
Asn Ala Thr Val
Asn Ala Val Thr
Asn Gly Ile Thr
Asn Gly Leu Thr
Asn Gly Thr Ile
Asn Gly Thr Leu
Asn Ile Ala Ser
Asn Ile Gly Thr
Asn Ile Ser Ala
Asn Ile Thr Gly
Asn Leu Ala Ser
Asn Leu Gly Thr
Asn Leu Ser Ala
Asn Leu Thr Gly
Asn Ser Ala Ile
Asn Ser Ala Leu
Asn Ser Ile Ala
Asn Ser Leu Ala
Asn Thr Ala Val
Asn Thr Gly Ile
Asn Thr Gly Leu
Asn Thr Ile Gly
Asn Thr Leu Gly
Asn Thr Val Ala
Asn Val Ala Thr
Asn Val Thr Ala
Gln Ala Ser Val
Gln Ala Val Ser
Gln Gly Ile Ser
Gln Gly Leu Ser
Gln Gly Ser Ile
Gln Gly Ser Leu
Gln Gly Thr Val
Gln Gly Val Thr
Gln Ile Gly Ser
Gln Ile Ser Gly
Gln Leu Gly Ser
Gln Leu Ser Gly
Gln Ser Ala Val
Gln Ser Gly Ile
Gln Ser Gly Leu
Gln Ser Ile Gly
Gln Ser Leu Gly
Gln Ser Val Ala
Gln Thr Gly Val
Gln Thr Val Gly
Gln Val Ala Ser
Gln Val Gly Thr
Gln Val Ser Ala
Gln Val Thr Gly
Ser Ala Ile Asn
Ser Ala Leu Asn
Ser Ala Asn Ile
Ser Ala Asn Leu
Ser Ala Gln Val
Ser Ala Val Gln
Ser Gly Ile Gln
Ser Gly Leu Gln
Ser Gly Gln Ile
Ser Gly Gln Leu
Ser Ile Ala Asn
Ser Ile Gly Gln
Ser Ile Asn Ala
Ser Ile Gln Gly
Ser Leu Ala Asn
Ser Leu Gly Gln
Ser Leu Asn Ala
Ser Leu Gln Gly
Ser Asn Ala Ile
Ser Asn Ala Leu
Ser Asn Ile Ala
Ser Asn Leu Ala
Ser Gln Ala Val
Ser Gln Gly Ile
Ser Gln Gly Leu
Ser Gln Ile Gly
Ser Gln Leu Gly
Ser Gln Val Ala
Ser Val Ala Gln
Ser Val Gln Ala
Thr Ala Asn Val
Thr Ala Val Asn
Thr Gly Ile Asn
Thr Gly Leu Asn
Thr Gly Asn Ile
Thr Gly Asn Leu
Thr Gly Gln Val
Thr Gly Val Gln
Thr Ile Gly Asn
Thr Ile Asn Gly
Thr Leu Gly Asn
Thr Leu Asn Gly
Thr Asn Ala Val
Thr Asn Gly Ile
Thr Asn Gly Leu
Thr Asn Ile Gly
Thr Asn Leu Gly
Thr Asn Val Ala
Thr Gln Gly Val
Thr Gln Val Gly
Thr Val Ala Asn
Thr Val Gly Gln
Thr Val Asn Ala
Thr Val Gln Gly
Val Ala Asn Thr
Val Ala Gln Ser
Val Ala Ser Gln
Val Ala Thr Asn
Val Gly Gln Thr
Val Gly Thr Gln
Val Asn Ala Thr
Val Asn Thr Ala
Val Gln Ala Ser
Val Gln Gly Thr
Val Gln Ser Ala
Val Gln Thr Gly
Val Ser Ala Gln
Val Ser Gln Ala
Val Thr Ala Asn
Val Thr Gly Gln
Val Thr Asn Ala
Val Thr Gln Gly
ACETIC ACID (2S,3S)-3-DIBENZYLAMINO-2-HYDROXY-4-PHENYLBUTYL ESTER
ACETIC ACID (2R,3S)-3-DIBENZYLAMINO-2-HYDROXY-4-PHENYLBUTYL ESTER
4-amino-5-chloro-N-[1-(cyclohex-3-en-1-ylmethyl)piperidin-4-yl]-2-prop-2-enoxybenzamide
Donitriptan
Donitriptan is a potent, high efficacy agonist at 5-HT1B/1D receptors with pKis of 9.4 and 9.3, respectively[1].
N-{5-carbamimidamido-1-[(naphthalen-2-yl)amino]-1-oxopentan-2-yl}benzamide
Diponium bromide
C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
Amotriphene
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent
(3Z)-3-[(2E,4E,6R)-1-hydroxy-6-[(3R,4R,6S)-6-hydroxy-1,4,8-trimethyl-2,9-dioxabicyclo[3.3.1]non-7-en-3-yl]-4-methylhepta-2,4-dienylidene]pyrrolidine-2,4-dione
N2,N6-bis[4-(dimethylamino)phenyl]pyridine-2,6-dicarboxamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[oxo(2-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(2-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(3-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclopropylmethyl)acetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
6beta-[N-(carboxymethylamino)carbonyl]methoxy-17beta-estradiol
n-[(2r,5s)-2,6-dihydroxy-5-[(3-hydroxyquinolin-2-yl)formamido]hexyl]-3-methylbutanimidic acid
2'-hydroxystemofoline
{"Ingredient_id": "HBIN005829","Ingredient_name": "2'-hydroxystemofoline","Alias": "NA","Ingredient_formula": "C22H29NO6","Ingredient_Smile": "CCC(CC12C3CCN1C4CC2OC35C4C(C(=C6C(=C(C(=O)O6)C)OC)O5)C)O","Ingredient_weight": "403.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10730","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "139031609","DrugBank_id": "NA"}